Pfizer Wants Rehearing in Generic Reglan Tardive Dyskinesia Case: Now, AttorneyOne Can Provide Advice

Share Article

As Forbes published on February 25th, 2013, Pfizer is asking the Alabama Supreme Court for a rehearing on its ruling that a patient who had only used generic versions of Reglan could sue the brand-name company. In light of these news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Reglan side effects.

Reglan: serious adverse events

Reglan: serious adverse events

ruling that a patient who had only used generic versions of Reglan could sue the brand-name company

AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively providing expert opinion in view of the recent news on Reglan Lawsuit.

As Forbes published on February 25th, 2013, Pfizer is asking the Alabama Supreme Court for a rehearing on its ruling that a patient who had only used generic versions of Reglan could sue the brand-name company (case no. 1:2010cv00602). Reglan (metoclopramide) is a drug used to help with the digestive process and reduce the symptoms of acid reflux and heartburn. It has been in the market since 1996. In the lawsuit plaintiff claims he took generic version of Reglan to treat his acid reflux and he developed tardive dyskinesia.

Another lawsuit was filed on December 10th, 2012, at Philadelphia Court of Common Pleas (case no. 121201046) and the plaintiff alleges he suffered tardive dyskinesia from his use of Reglan.

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Reglan severe complications. Sean Burke, director of Media Relations for AttorneyOne.com, adds that the relevant information illustrates that people continue to file Reglan lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

In November 2010, the FDA issued a warning on Reglan (metoclopramide) stating that “Treatment with metoclopramide can cause tardive dyskinesia (TD), a potentially irreversible and disfiguring disorder characterized by involuntary movements of the face, tongue, or extremities. The risk of developing tardive dyskinesia increases with the duration of treatment and the total cumulative dose.”

AttorneyOne.com has further information on Reglan lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/2/prweb10463936.htm

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
AttorneyOne
1-877-230-7343
Email >
Visit website